HOT TAKE: Data Quality, Retractions, and What It Means for Medical Research
By DocWire News Editors - Last Updated: April 25, 2023Dr. Payal Kohli, a cardiologist based in Denver, CO, and section adviser for the Cardiology section of DocWire News, gives us a Hot Take and talks about the recent high-profile retractions of hydroxychloroquine studies in the New England Journal of Medicine and The Lancet, as well as her thoughts on what it means for medical research going forward. Read our previous coverage of the retractions here.
Advertisement
Post Tags:hydroxychloroquine
Advertisement
Related Posts
Dr. Kohli discusses the SELECT trial, which showed that semaglutide can benefit obese patients with heart disease.
Dr. Payal Kohli weighs in on Bronny James' cardiac arrest scare and what the event means for his future.
Dr. Payal Kohli talks about the dangerous association between air pollutants and cardiovascular events.
Dr. Payal Kohli talks about the how mental health impacts cardiovascular health, and vice versa.
Dr. Payal Kohli talks about the symptoms and dangers of meningitis, and whether or not it poses a public health threat.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.